Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Neovascular Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03345082
What this trial is testing

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 366
Large-scale testing (Phase 3)Study completedNCT00891735
What this trial is testing

Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

Who this might be right for
Age-related Macular Degeneration
Genentech, Inc. 1,097
Early research (Phase 1)Active Not RecruitingNCT06825858
What this trial is testing

A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04657289
What this trial is testing

The Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 451
Not applicableEnrolling By InvitationNCT07660640
What this trial is testing

Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

Who this might be right for
Age-Related Macular Degeneration (AMD)Non-Neovascular Age-Related Macular Degeneration
Perceive Biotherapeutics, Inc. 88
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Early research (Phase 1)Study completedNCT05105607
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 16
Not applicableUnknownNCT04882956
What this trial is testing

BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration

Who this might be right for
Macula Lutea Degeneration
Benha University 40
Post-approval studies (Phase 4)Study completedNCT02581891
What this trial is testing

Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye

Who this might be right for
Macular Degeneration
Bayer 287
Early research (Phase 1)Study completedNCT05903794
What this trial is testing

EXG102-031 in Patients With wAMD (Everest)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Exegenesis Bio 12
Early research (Phase 1)Study completedNCT05345769
What this trial is testing

Safety and Efficacy of AM712 in Patients with NAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
AffaMed Therapeutics Limited 21
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT03479372
What this trial is testing

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
PanOptica, Inc. 51
Not applicableStudy completedNCT05834075
What this trial is testing

A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India

Who this might be right for
Neurovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 63
Not applicableStudy completedNCT01942213
What this trial is testing

Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

Who this might be right for
Neovascular Age Related Macular Degeneration
Prism Vision Group 136
Testing effectiveness (Phase 2)Study completedNCT04304755
What this trial is testing

Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Oslo University Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT02511613
What this trial is testing

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Ohr Pharmaceutical Inc.
Not applicableStudy completedNCT05657158
What this trial is testing

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Who this might be right for
Intraocular InflammationRetinal Vascular Occlusion
Novartis Pharmaceuticals 198
Not applicableNot Yet RecruitingNCT05507840
What this trial is testing

Photobiomodulation for Dry Age Related Macula Degeneration

Who this might be right for
PhotobiomodulationAge-Related Macular Degeneration
Oslo University Hospital 121
Testing effectiveness (Phase 2)Ended earlyNCT00464347
What this trial is testing

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 100
Next Page